Mild cognitive impairment and kidney disease: clinical aspects

被引:57
|
作者
Viggiano, Davide [1 ]
Wagner, Carsten A. [2 ,3 ]
Blankestijn, Peter J. [4 ]
Bruchfeld, Annette [5 ]
Fliser, Danilo [6 ]
Fouque, Denis [7 ]
Frische, Sebastian [8 ]
Gesualdo, Loreto [9 ,10 ]
Gutierrez, Eugenio [11 ]
Goumenos, Dimitrios [12 ]
Hoorn, Ewout J. [13 ]
Eckardt, Kai-Uwe [14 ]
Knauss, Samuel [15 ,16 ,17 ,18 ]
Koenig, Maximilian [14 ]
Malyszko, Jolanta [19 ]
Massy, Ziad [20 ,21 ]
Nitsch, Dorothea [22 ]
Pesce, Francesco [9 ,10 ]
Rychlik, Ivan [23 ]
Soler, Maria Jose [24 ]
Spasovski, Goce [25 ]
Stevens, Kathryn I. [26 ]
Trepiccione, Francesco [1 ,27 ]
Wanner, Christoph [28 ]
Wiecek, Andrzej [29 ]
Zoccali, Carmine [30 ]
Unwin, Robert [31 ,32 ]
Capasso, Giovambattista [1 ,27 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, Naples, Italy
[2] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland
[3] Natl Ctr Competence Res NCCR Kidney CH, Zurich, Switzerland
[4] Univ Med Ctr, Dept Nephrol, Utrecht, Netherlands
[5] Karolinska Inst, Dept Renal Med, CLINTEC, Karolinska Univ Hosp, Stockholm, Sweden
[6] Saarland Univ, Med Ctr, Dept Internal Med Nephrol & Hypertens 4, Homburg, Germany
[7] Univ Lyon, Ctr Hosp Lyon Sud, Dept Nephrol, Dialysis,Nutr, F-69495 Pierre Benite, France
[8] Univ Aarhus, Dept Biomed, Aarhus, Denmark
[9] Azienda Osped Univ Policlin, Div Nephrol, Bari, Italy
[10] Univ Aldo Moro Bari, Bari, Italy
[11] Univ Aarhus, Dept Clin Med, Ctr Functionally Integrat Neurosci, Aarhus, Denmark
[12] Univ Hosp Patras, Dept Nephrol, Patras, Greece
[13] Univ Med Ctr Rotterdam, Div Nephrol & Transplantat, Erasmus Med Ctr, Dept Internal Med, Rotterdam, Netherlands
[14] Charite Univ Med Berlin, Dept Nephrol & Med Intens Care, Berlin, Germany
[15] Charite Univ Med Berlin, Klin Neurol Expt Neurol, Berlin, Germany
[16] Free Univ Berlin, Berlin, Germany
[17] Humboldt Univ, Berlin, Germany
[18] DZHK, Berlin Inst Hlth, Berlin, Germany
[19] Warsaw Med Univ, Dept Nephrol Dialysis & Internal Med, Warsaw, Poland
[20] Paris Ile de France West Univ UVSQ, Ambroise Pare Hosp, AP HP, Div Nephrol, Boulogne Billancourt Par, France
[21] INSERM, U1018, Team5, Villejuif, France
[22] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England
[23] Charles Univ Prague, Dept Internal Med 1, Fac Med 3, Prague, Czech Republic
[24] Hosp Univ Vall dHebron, VHIR, Nephrol Res Grp, Dept Nephrol, Barcelona, Spain
[25] Univ Skopje, Fac Med, Dept Nephrol, Skopje, Former Yugoslav, North Macedonia
[26] Queen Elizabeth Univ Hosp, Glasgow Renal & Transplant Unit, Glasgow, Lanark, Scotland
[27] Biogem, Dept Genet & Translat Med, Ariano Irpino, Italy
[28] Univ Hosp, Div Nephrol, Dept Med, Wurzburg, Germany
[29] Med Univ Silesia, Dept Nephrol Transplantat & Internal Med, Katowice, Poland
[30] Osped Riuniti Reggio Calabria, CNR, IFC, Reggio Di Calabria, Italy
[31] UCL, Ctr Nephrol, Royal Free Campus, London, England
[32] AstraZeneca IMED ECD CVRM R&D, Gothenburg, Sweden
关键词
QUALITY-OF-LIFE; BASAL GANGLIA LESIONS; BLOOD-BRAIN-BARRIER; HEMODIALYSIS-PATIENTS; PERITONEAL-DIALYSIS; ALZHEIMERS-DISEASE; DIABETIC UREMIA; DEMENTIA; DEPRESSION; ADULTS;
D O I
10.1093/ndt/gfz051
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Chronic kidney disease (CKD) is now seen as a systemic disease involving also the central nervous system [1], but the link between the kidney and different organ systems and disease went unnoticed for a long time. The king of Poland, Stephen Bathory (1533-86), suffered from CKD due to polycystic kidney disease and depression [2]. Similarly, Wolfgang Amadeus Mozart was also thought to have had CKD [3] and depression [4]. A list of 'Famous People Who Have Died from Kidney Disease' [5] includes many who suffered from both CKD and depression or other signs of mental illness. Is this a coincidence or actually evidence of a link between kidney disease and brain dysfunction? This is not merely an academic question because all forms of mental illness can seriously impair an individual's quality of life, and are frequently associated with progression of diseases and premature mortality, so it is worth the effort of trying to answer it. Europe and much of the industrialized countries are experiencing growing numbers of patients with CKD within their ageing populations [6]. CKD is complex and potentially fatal: (i) all organs are affected, sooner or later; (ii) the balance of plasma volume, electrolytes, acid-base and minerals, metabolites, hormones and proteins is disturbed; and (iii) patients often need a multidisciplinary team approach managing complex comorbidities, drug regimens and special diets. Although the prognosis of patients with CKD remains poor, their increasing life expectancy has shifted medical attention from life-threatening emergencies to long-term complications and sequelae, and how to improve quality of life [7]. Indeed, kidney failure has detrimental effects on health-related quality of life (HRQoL), reaching levels similar to those seen in patients with metastatic cancer [8]. This might be due to psychological factors, both kidney disease and cancer being chronic diseases with a bad prognosis. However, although the effect of CKD on quality of life is more evident in advanced stages (stage G4P) and in older patients [9, 10], a large study has shown a significant decrease in HRQoL as early as CKD stage G2 [11]. Notably, neurological and cognitive impairments [12], and depression [13] are among the most debilitating consequences of CKD contributing to the significantly reduced HRQoL [14]. © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. 10 EDITORIAL.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 50 条
  • [31] Clinical outcome of amnestic mild cognitive impairment
    Petersen, RC
    Boeve, BF
    Knopman, DS
    Smith, GE
    Edland, SD
    NEUROLOGY, 2002, 58 (07) : A237 - A238
  • [32] Mild cognitive impairment - Clinical characterization and outcome
    Petersen, RC
    Smith, GE
    Waring, SC
    Ivnik, RJ
    Tangalos, EG
    Kokmen, E
    ARCHIVES OF NEUROLOGY, 1999, 56 (03) : 303 - 308
  • [33] The clinical course of patients with mild cognitive impairment
    Lautenschlager, NT
    Diehl, J
    Riemenschneider, M
    Kurz, AF
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S162 - S163
  • [34] Mild cognitive impairment: issues of clinical practice
    Kyziridis, Th
    Theofilidis, A.
    SCIENTIFIC CHRONICLES, 2019, 24 (04) : 506 - 525
  • [35] Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer's disease
    Ryu, Seon Young
    Lee, Sang Bong
    Kim, Tae Woo
    Lee, Taek Jun
    ACTA NEUROLOGICA BELGICA, 2016, 116 (04) : 535 - 541
  • [36] Clinical and imaging correlations in mild cognitive impairment
    Podea, D. M.
    Ciobanu, G.
    Piros, L. E.
    Mila, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 140 - 140
  • [37] CLINICAL COURSE OF PATIENTS WITH A MILD COGNITIVE IMPAIRMENT
    PETERSEN, RC
    SMITH, GE
    TANGALOS, EG
    KOKMEN, E
    IVNIK, RJ
    NEUROLOGY, 1993, 43 (04) : A277 - A277
  • [38] Outcome of clinical subtypes of mild cognitive impairment
    Petersen, RC
    Ivnik, RJ
    Boeve, BF
    Knopman, DS
    Smith, GE
    Tangalos, EG
    NEUROLOGY, 2004, 62 (07) : A295 - A295
  • [39] Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer’s disease
    Seon Young Ryu
    Sang Bong Lee
    Tae Woo Kim
    Taek Jun Lee
    Acta Neurologica Belgica, 2016, 116 : 535 - 541
  • [40] Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Goldman, Jennifer G.
    Weis, Holly
    Stebbins, Glenn
    Bernard, Bryan
    Goetz, Christopher G.
    MOVEMENT DISORDERS, 2012, 27 (09) : 1129 - 1136